Women’s health and clinical trials
AUTOR(ES)
Schiebinger, Londa
FONTE
American Society for Clinical Investigation
RESUMO
Women have traditionally been underrepresented in clinical trials. In order to translate recent advances in our understanding of the molecular and physiological bases of sex differences into new therapeutics and health practices, sound sex-specific clinical data are imperative. Since the founding of the Office of Research on Women’s Health within the Office of the Director at the NIH in 1990, inequities in federally funded biomedical research, diagnosis, and treatment of diseases affecting women in the US have been reviewed. Discussed herein is the evolution of gender-related research innovations, primarily within the last decade, and strategies and challenges involved in the success of this recent development.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=198535Documentos Relacionados
- Methodological quality of systematic reviews and clinical trials on women's health published in a Brazilian evidence-based health journal
- Isoflavones and women's health
- Obstetrics, Gynaecology and Women's Health
- Women's Health and Women's Leadership in Academic Medicine: Hitting the Same Glass Ceiling?
- Update in Women’s Health